Skip to content

Efficacy and Safety of Xingnao Kaiqiao acupuncture technique by using intradermal needles for Gastrointestinal Dysfunction after Laparoscopic Surgery: a Single-Center, Double-Blind, Randomized, and Controlled Trial

Efficacy and Safety of Xingnao Kaiqiao acupuncture technique by using intradermal needles for Gastrointestinal Dysfunction after Laparoscopic Surgery: a Single-Center, Double-Blind, Randomized, and Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17010763
Enrollment
Unknown
Registered
2017-03-02
Start date
2017-03-02
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Dysfunction

Interventions

Xingnao Kaiqiao acupuncture technique by using intradermal needles :Xingnao Kaiqiao acupuncture technique by using intradermal needles to PC6, DU26, SP06
Placebo:Xingnao Kaiqiao placebo acupuncture technique by using intradermal needles to PC6, DU26, SP06

Sponsors

Tianjin Nankai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) must be aged 18 to 65 years; 2) selective operation on laparoscopic surgery anesthesia; 3) have no experience of intradermal needling before this study; 4) are not involved in any other clinical trials during the same period; 5) do not have cognitive impairment, aphasia, or mental disorders, thereby possessing unimpaired communication ability, and can understand and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) are pregnant or lactating; 2) have a history of abdominal surgery; 3) have undergone more procedures than LC alone as part of their treatment; 4) have sustained damage to the selected acupoints; 5) have an allergy to the adhesive; 6) suffer from severe gastrointestinal or chronic pain disorders (such as chronic pelvic pain), and have taken analgesic drugs during the past 48 hor over a long period of time; 7) have a serious disease of the heart, brain, liver, kidney, or hematopoietic system; 8) have a history of drug abuse (e.g., morphine), motor-induced or surgery-induced vomiting, obesity (body weight > 80 kg), diabetes, or are bedridden.

Design outcomes

Primary

MeasureTime frame
first passage of flatus;

Secondary

MeasureTime frame
Time to first defecation;Abdominal pain;Abdominal distention;Nausea;Vomit;Blood Gerhlin;The hospital anxiety depression scale (HADS);the Gastrointestinal Quality of Life Index,GIQLI;

Countries

China

Contacts

Public ContactJinting Li

Tianjin Nankai Hospital

nkyywzk@163.com+86 18698087263

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 8, 2026